Organisation:
NICE
Consultation:
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes ID1653
Status:
Submitted
NICE accredited clinical practice guidelines
Analyses about the care provided to patients at UK renal centres.
A report on the nationwide collection of AKI warning test scores.